AP7088b
antibody from Abcepta
Targeting: CERK
dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AP7088b - Provider product page
- Provider
- Abcepta
- Proper citation
- Abgent Cat#AP7088b, RRID:AB_2077241
- Product name
- CERK Antibody (C-term)
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Purified Rabbit Polyclonal Antibody (Pab)
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 400 µl
- Concentration
- 2 mg/ml
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references ATRA inhibits ceramide kinase transcription in a human neuroblastoma cell line, SH-SY5Y cells: the role of COUP-TFI.
Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome.
Ceramide kinase promotes Ca2+ signaling near IgG-opsonized targets and enhances phagolysosomal fusion in COS-1 cells.
Murakami M, Ito H, Hagiwara K, Yoshida K, Sobue S, Ichihara M, Takagi A, Kojima T, Tanaka K, Tamiya-Koizumi K, Kyogashima M, Suzuki M, Banno Y, Nozawa Y, Murate T
Journal of neurochemistry 2010 Jan;112(2):511-20
Journal of neurochemistry 2010 Jan;112(2):511-20
Cardiovascular inflammation and lesion cell apoptosis: a novel connection via the interferon-inducible immunoproteasome.
Yang Z, Gagarin D, St Laurent G 3rd, Hammell N, Toma I, Hu CA, Iwasa A, McCaffrey TA
Arteriosclerosis, thrombosis, and vascular biology 2009 Aug;29(8):1213-9
Arteriosclerosis, thrombosis, and vascular biology 2009 Aug;29(8):1213-9
Ceramide kinase promotes Ca2+ signaling near IgG-opsonized targets and enhances phagolysosomal fusion in COS-1 cells.
Hinkovska-Galcheva V, Clark A, VanWay S, Huang JB, Hiraoka M, Abe A, Borofsky M, Kunkel RG, Shanley T, Shayman JA, Lanni F, Petty HR, Boxer LA
Journal of lipid research 2008 Mar;49(3):531-42
Journal of lipid research 2008 Mar;49(3):531-42
No comments: Submit comment
Supportive validation
- Submitted by
- Abcepta (provider)
- Main image
- Experimental details
- The anti-CERK Pab (Cat. #AP7088b) is used in Western blot to detect CERK in mouse heart tissue lysate (Lane 1) and A2058 cell lysate (Lane 2).
- Primary Ab dilution
- 1:1000